mutLBSgeneDB |
Gene summary for ZNF423 |
Gene summary |
Basic gene Info. | Gene symbol | ZNF423 |
Gene name | zinc finger protein 423 | |
Synonyms | Ebfaz|JBTS19|NPHP14|OAZ|Roaz|ZFP423|Zfp104 | |
Cytomap | UCSC genome browser: 16q12 | |
Type of gene | protein-coding | |
RefGenes | NM_001271620.1, NM_015069.3, | |
Description | OLF-1/EBF associated zinc fingerSmad- and Olf-interacting zinc finger proteinearly B-cell factor associated zinc finger proteinhOAZolf1/EBF-associated zinc finger protein | |
Modification date | 20141207 | |
dbXrefs | MIM : 604557 | |
HGNC : HGNC | ||
Ensembl : ENSG00000102935 | ||
HPRD : 05189 | ||
Vega : OTTHUMG00000173491 | ||
Protein | UniProt: Q2M1K9 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ZNF423 | |
BioGPS: 23090 | ||
Pathway | NCI Pathway Interaction Database: ZNF423 | |
KEGG: ZNF423 | ||
REACTOME: ZNF423 | ||
Pathway Commons: ZNF423 | ||
Context | iHOP: ZNF423 | |
ligand binding site mutation search in PubMed: ZNF423 | ||
UCL Cancer Institute: ZNF423 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0045892 | negative regulation of transcription, DNA-templated | 10660046 | GO:0045893 | positive regulation of transcription, DNA-templated | 10660046 |
Top |
Ligand binding site mutations for ZNF423 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | C932 | C930Y | STAD | 1 | H952 | L953R | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for ZNF423 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for ZNF423 from PDB |
Top |
Differential gene expression and gene-gene network for ZNF423 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for ZNF423 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C3539071 | NEPHRONOPHTHISIS 14 | 1 | GeneticVariation |
umls:C0236733 | Amphetamine-Related Disorders | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for ZNF423 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of ZNF423 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of ZNF423 |
Multiple alignments for Q2M1K9 in multiple species |
LBS | AA sequence | # species | Species | C932 | KGSHKCNVCSR | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C932 | KGNHKCNVCSR | 1 | Danio rerio | C935 | HKCNVCSRTFF | 4 | Homo sapiens, Danio rerio, Mus musculus, Rattus norvegicus | H948 | NGLREHLQTHR | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | H948 | NGLREHAQTHR | 1 | Danio rerio | H952 | EHLQTHRGPAK | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | H952 | EHAQTHRGPAK | 1 | Danio rerio |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |